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Abstract 
Comparison of Methods of Measuring Electronic Cigarette Puff Topography 
 
Nicholas Felicione 
To evaluate properly the potential benefits and harms of electronic cigarettes (ECIGs), it 
is important to evaluate how individuals puff from an electronic cigarette, or their puff 
topography. This measure, which includes indices of puff number, duration, volume, interpuff 
interval, and flow rate, can be used to predict exposure to toxicants including nicotine. Puff 
topography has been studied extensively for cigarette smokers, but not ECIG users. The studies 
that have involved electronic cigarette topography measurement have done so using devices that 
have not been thoroughly validated or proven reliable. Thus, the purpose of this study was to 
evaluate methods of measuring electronic cigarette puff topography. Twelve participants (seven 
ECIG-experienced users, five ECIG-naïve cigarette smokers) completed three Latin-square 
ordered sessions that differed by topography measurement method: eTop 2.0, eTop, or natural 
observation via video recording. Following > 12 hours of nicotine/tobacco abstinence, 
participants engaged in three bouts of ECIG puffing: one 10-puff directed bout and two ad lib 
bouts. Additionally, subjective ratings of nicotine/tobacco withdrawal and product effects were 
evaluated before and after each ECIG bout. Puff topography did not differ between measurement 
methods or between groups (p’s > 0.05). Measurement of smoking topography differed little 
between the mouthpiece-based device and direct observation methods. Puff duration, number, 
and IPI were correlated highly across measurement methods (all r’s > 0.68). All methods were 
also reliable, as demonstrated by high correlations across cigarette bouts within each condition 
(most r’s > 0.78). Ratings of withdrawal and product effects changed from baseline to post-
directed bout and post-ad lib bout, potentially suggesting nicotine delivery 
  
from the electronic cigarette. Due to the low sample size, definitive conclusions cannot be 
determined from this study. Further research should continue to evaluate these measurements 
with a sample size appropriately powered to detect differences between measurement methods 
and groups.  
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Chapter 1 - Introduction 
 
Approximately 18% of adults in the United States (U.S.), or 42 million people, are 
current cigarette smokers (CDC, 2014). Cigarette smoking accounts for over 480,000 deaths in 
the U.S. each year, making it the leading preventable cause of disease and death (USDHHS, 
2014). Smoking is responsible for almost 90% of all cases of lung cancer and 80% of cases of 
chronic obstructive pulmonary disease (COPD) (USDHHS, 2004). These health problems are 
directly linked to a variety of harmful chemicals found in tobacco products and tobacco smoke. 
According to the Food and Drug Administration (FDA, 2012), tobacco smoke contains more 
than 7,000 chemicals, with 93 classified as harmful or potentially harmful constituents. For 
example, carbon monoxide (CO) has been linked to cardiovascular and respiratory disease and 
tobacco-specific nitrosamines have been linked to cancer (USDHHS, 2012). 
These risks associated with such tobacco-related diseases are significantly reduced when 
smokers quit. Specifically, smoking cessation lowers a smoker’s risk of death from 
cardiovascular disease and COPD, and is the only strategy to reduce the development of cancers 
caused by carcinogens in tobacco smoke (USDHHS, 1990; USDHHS, 2010). Weeks to months 
after quitting, a smoker’s lung function starts to restore, with decreased coughing and shortness 
of breath (USDHHS, 2004). Fifteen years after quitting, a former smoker’s risk of heart disease 
and stroke is equivalent to that of a non-smoker (IARC, 2007; USDHHS, 2004). Additionally, 
smokers who achieve complete cessation before age 40 can reduce risk of premature death to 
levels of a nonsmoker (USDHHS, 1990; USDHHS, 2004). Despite the known benefits of 
smoking cessation, many smokers are unable to quit. Almost 70% of current smokers report a 
desire to quit completely, and each year more than half of smokers make a quit attempt (CDC, 
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2011; CDC, 2014). Unfortunately, less than 10% of smokers successfully quit in a given year 
(CDC, 2011; Messer, Trinidad, Al-Dalaimy, & Pierce, 2008). 
The difficulty of sustaining smoking cessation might be improved with the use of 
counseling, nicotine replacement therapy (NRT), and/or non-nicotine prescription medications. 
In recent years, 31.7% of smokers used a pharmacotherapy or engaged in counseling to attempt 
to quit smoking (CDC, 2014). While these approaches may improve cessation rates for some 
smokers (Cahill, Stevens, Perera, & Lancaster, 2013; Fiore et al., 2009), their overall impact has 
been minimal. For example, while smokers who use an NRT product like the lozenge reveal 
higher initial abstinence rates than smokers who do not use an NRT product, this difference 
diminishes within six months of use (Fraser et al., 2014). Similarly, the use of varenicline 
(Chantix®), an approved cessation medication for smokers, significantly increases abstinence 
rates relative to placebo, but not long-term abstinence (Agaboola, Coleman, McNeill, & 
Leonardi-Bee, 2015; Aubin et al., 2008; Eisenberg et al., 2008; Gonzales et al., 2006). 
Additionally, both telephone and face-to-face counseling have failed to increase abstinence rates 
above pharmacotherapy use or no counseling groups (McCarthy et al., 2008; Sims et al., 2012). 
Such suboptimal long-term outcomes for currently available treatments have led some smokers 
to turn to unconventional, and often controversial, products. Collectively, these products have 
been deemed as Modified Risk Tobacco Products (MRTPs). 
Modified Risk Tobacco Products 
MRTPs are products that have been developed and/or marketed as “harm reduction” 
products (Public Law 111-31, 2009). That is, these products have been touted as a way for 
smokers to reduce or replace their cigarettes in an attempt to reduce the harms associated with 
smoking (Stratton et al., 2001). Under this scenario, tobacco-related morbidity and mortality 
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rates would decrease despite the continual use of nicotine/tobacco products. For example, 
tobacco-related health problems are notably lower in Sweden relative to the U.S., though 
prevalence rates of tobacco snus use among males alone are above 25% (Norberg, Malmberg, 
Ng, & Broström, 2011; Norberg, Malmberg, Ng, & Broström, 2015). Snus consists of moist 
tobacco, packaged in a small pouch, that is cured so as to limit formation of carcinogens (i.e., 
tobacco-specific nitrosamines) (Foulds et al., 2003).  Smokers who switch from cigarettes to snus 
reveal substantially reduced risk for oral cancer, lung cancer, and respiratory and cardiovascular 
disease, relative to smokers who continue to use cigarettes (Lee, 2013; Luo et al., 2007). Such 
findings provide support for proponents of the harm reduction approach to tobacco use. 
More recently, a popular product promoted as a MRTP is that of an electronic cigarette 
(ECIG). ECIGs were patented in 2004 and entered the U.S. market in 2007 (Pauly, Li, & Barry, 
2007). Two years later, ECIGs were more commonly searched on the Internet than snus or NRTs 
(Ayers, Ribisl, & Brownstein, 2011). Surveys demonstrate that ECIG use has more than doubled 
among both adolescent and adult samples (CDC, 2013; King, Patel, Nguyen, & Dube, 2015). 
While ECIG use is more common among smokers than non-smokers (King et al., 2015; Sutfin, 
McCoy, Morrell, Hoeppner, & Wolfson, 2013), a notable portion of never smokers have also 
tried an ECIG (McMillin et al., 2014). Given their popularity on the U.S. market, the scientific 
community is eager to learn more about the influence of ECIGs on individual and population 
health. It remains unknown, however, whether ECIGs have the potential to offer a viable harm 
reduction strategy for current tobacco users. 
Electronic Cigarettes 
The FDA defines ECIGs as a “battery-operated products designed to deliver nicotine, 
flavor and other chemicals. They turn chemicals, including highly addictive nicotine, into an 
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aerosol that is inhaled by the user.” (FDA, 2014). All ECIG devices share features of a solution 
storage component (e.g., tank or cartridge), a battery, a heating element (e.g., resistance wire 
coil), and a flow sensor (Brown & Cheng, 2014). Typically, the flow sensor is activated by a 
change in pressure caused by puffing, leading to activation of the battery.  The battery provides 
power to the heating element, containing a wick saturated in “e-liquid” (solution containing 
nicotine and other ingredients) and an atomizer to aerosolize the liquid. The user would then 
inhale the aerosol through the mouthpiece, a process more commonly known as “vaping”. Still, 
the type and combination of these features may vary widely across devices (Brown & Cheng, 
2014).  
The first generation of ECIG devices are referred to as “cig-alikes” given that they model 
the design of a cigarette, with a mouthpiece that resembles a cigarette filter and a LED light that 
resembles the burning end of the cigarette rod (Cassidy, 2011; Etter, 2012). Cig-alikes may be 
disposable or reusable (i.e., rechargeable battery and replaceable cartridge) (Cassidy, 2011; 
Grana et al., 2014).  These early devices typically came with cartridges pre-filled with the e-
liquid solution. The second generation of ECIG devices generally do not resemble traditional 
cigarettes (Etter, 2012). These ECIGs may hold the e-liquid in a combined cartridge and 
atomizer (cartomizer) or in a tank system, in which the individual can refill their e-liquid as 
needed. Second generation ECIGs also have batteries that are manually operated, and usually 
have a higher voltage capacity than first generation ECIGs (Farsalinos et al., 2014). Also notable 
is that the user has some freedom to choose the nicotine content (i.e., 0 to 36 mg/ml) and the 
ratio of certain ingredients of their e-liquid. 
 Importantly, exposure to ECIG ingredients, including nicotine, may be influenced not 
only by these device and liquid characteristics, but also by user behavior. The amount of nicotine 
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emitted per second, the “nicotine flux”, is suggested to vary greatly within and across ECIG 
devices (Shihadeh & Eissenberg, 2015). For instance, some ECIG designs are unlikely to deliver 
pharmacologically active doses of nicotine, while other designs are likely to deliver levels of 
nicotine that far surpass those of a cigarette (Shihadeh & Eissenberg, 2015). High nicotine flux 
may expose a user to nicotine concentrations that have the potential to increase dependence or 
produce toxic outcomes (Shihadeh & Eissenberg, 2015). Additionally, the user may alter the 
manner in which they puff on their ECIG in an attempt to circumvent such design features. All of 
these factors could interact in countless ways to impact user exposure to ECIG ingredients like 
nicotine, as described below. 
ECIG device and e-liquid characteristics. Characteristics of an ECIG that may 
influence nicotine delivery include battery voltage (Goniewicz, Kuma, Gawron, Knysak, & 
Kosmider, 2013; Shihadeh & Eissenberg, 2015). For example, using digitally produced ECIG 
puffs, increasing the battery voltage of a cig-alike model from 3.3 volts (V) to 5.2V results in 
higher nicotine yields and increased total particulate matter (i.e., total aerosolized constituents) 
(Talih et al., 2015). Similarly, increasing the battery voltage of a tank model from 3.3V to 5.5V 
increases nicotine yield from .30mg to 1.18mg, as well as increases the production of toxic 
carbonyl compounds (Kosmider et al., 2014a). 
Differences in the nicotine yield of ECIGs are also likely impacted by the temperature of 
the e-liquid (Trehy et al., 2011), which is affected by both the battery and the heating element. 
Notable is that second generation ECIGs, which result in higher plasma nicotine levels in users, 
contain higher-capacity batteries and larger atomizers to more effectively provide power to the 
atomizer (Farsalinos et al., 2014). Another comparison of ECIG types noted the varying efficacy 
of different ECIGs to aerosolize the relative amount of nicotine present in the e-liquid, with a 
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range from 21% to 85% (Goniewicz et al., 2013). Trtchounian et al. (2010) reported differences 
within and across brands of ECIGs in density of aerosol production from the beginning to end of 
a cartridge, indicating variability in nicotine delivery and constituent exposure. The latter two 
findings may indicate variability in the heating process both between and within ECIG designs,  
Manipulations in the content of e-liquid are also implicated in user exposure to nicotine 
and other constituents.  E-liquid usually consists of some combination of nicotine, flavoring, and 
a humectant, most popularly propylene glycol (PG) and vegetable glycerin (VG) (Hahn et al., 
2014).  The concentration of these ingredients may be altered, resulting in differential nicotine 
and toxicant yield between e-liquid brands. Not surprisingly, higher nicotine concentrations lead 
to higher nicotine yield (Talih et al., 2015) and also higher levels of nicotine delivery to the user 
(Hiler et al., 2015). Interestingly, the ratio of other ingredients may also affect the nicotine yield 
of ECIGs. For example, increased levels of PG relative to VG increase the nicotine emitted per 
puff using machine-generated ECIG puffs (Kosmider et al., 2014a). Additionally, PG may be 
more susceptible to decomposition at high temperatures compared to VG, resulting in a greater 
yield of toxic carbonyls (Kosmider et al., 2014b).  
A related concern involves the inconsistency between the actual nicotine content of e-
liquid versus what is listed on the product label (Davis, Dang, Kim, & Talbot, 2015; Goniewicz 
et al., 2013; Trehy et al., 2011). The nicotine content of some cartomizers varies by more than 
50% of that labeled (Trehy et al., 2011). Also, some tested e-liquids labeled nicotine showed 
large variability in the actual nicotine content (Lisko, Tran, Stanfill, Blount, & Watson, 2015; 
Trehy et al., 2011). A similar pattern has been observed with the refillable e-liquid for tank 
system ECIGs, with nicotine concentrations ranging from 1-90% of the labeled content (Davis et 
al., 2015; Goniewicz et al., 2013). In fact, some brands of e-liquid labeled as 0mg nicotine 
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actually contain upwards of 21mg, and those labeled as 16mg have contained 6mg nicotine or 
less (Trehy et al., 2011).  
Regardless of the device or e-liquid features of the ECIG model used, a nicotine 
dependent user is expected to adapt their behavior to achieve an optimal level of nicotine. 
Specifically, the manner in which a user puffs on an ECIG may change as a function of the 
qualities of the device and/or the e-liquid (Shihadeh & Eissenberg, 2015). This phenomenon, 
known as compensatory responding, has been demonstrated in the past when cigarette design 
characteristics are manipulated (Benowitz, 2001; Herning, Jones, Bachman, & Mines, 1981; 
Zacny & Stitzer, 1988). In fact, users’ behavior can negate a certain product design features. 
User Characteristics. Users’ puffing behavior, as measured by puff topography, can be 
quantified using the variables of puff number, duration (measured in seconds), volume 
(measured in milliliters), inter-puff interval (IPI; measured in seconds), and flow rate (measured 
in milliliters per second). Measurement of these topography parameters is crucial for 
understanding the relationship between nicotine yield (the amount of nicotine able to be emitted 
from a product) and nicotine delivery (the amount of nicotine absorbed by the user). The 
importance of topography measurement is demonstrated by the relatively weak correlation 
between the nicotine yield of a cigarette (regular, light, or ultralight; measured by U.S. Federal 
Trade Commission) and the plasma nicotine concentration in a user (Benowitz et al., 1983). 
Light brand cigarettes yield lower levels of nicotine than regular brand cigarettes due to various 
design features (e.g., vent holes which dilute the smoke upon inhalation). However, smokers’ 
plasma nicotine levels typically do not differ as a function of which cigarette yield they smoke 
(Benowitz et al., 1983; Kozlowski, O’Connor, Sweeney, 2001). This discrepancy may be 
explained by user behavior.  
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Zacny & Stitzer (1988) had participants smoke five cigarettes with different nicotine 
yields (0.1 mg – 1.1mg), and each cigarette yield was smoked for one week. Increases in average 
and total puff volume, and decreases in IPI, were associated with lower-yield cigarettes. A 
similar pattern of results has been demonstrated when smokers of regular, higher-yield cigarettes 
switch to lower-yield cigarettes. Changes in puffing behavior have been repeatedly demonstrated 
when a smoker switches to a low-yield cigarette (Blank, Disharoon, & Eissenberg, 2009; Evans, 
Buchhalter, Kleykamp, & Eissenberg, 2003; Hammond, Fong, Cummings, & Hyland, 2005; 
Herning et al., 1981). This more intense puffing profile for lower-yield cigarettes has been 
attributed to the purpose of achieving optimal nicotine levels in the blood (Djordjevic, Hoffman, 
& Hoffman, 1997; Sutton et al., 1982). That is, smokers may take more (number), bigger 
(volume), longer (duration), and/or more frequent (IPI) puffs in order to compensate for the 
lower levels of nicotine delivered with each puff (Blank et al., 2009; Kozlowski et al., 2001; 
Zacny & Stitzer, 1988). Consequently, smokers who switch to lower nicotine yield cigarettes do 
not expose themselves to lower levels of nicotine or other harmful toxicants (Benowitz, Jacob, 
Kozlowski, & Yu, 1986; Hecht et al., 2005).  These same compensatory responses may also be 
observed among ECIG users. 
Acute ECIG use by a naïve user seems to be ineffective for nicotine delivery (Vansickel, 
Cobb, Weaver, & Eissenberg, 2010). However, similarly designed studies with experienced 
ECIG users reveal approximately 5-fold increases in plasma nicotine concentrations following 
acute vaping (Dawkins & Corcoran, 2014; Vansickel & Eissenberg, 2013). Additionally, when 
ECIG-naïve cigarette smokers are followed over 4 weeks of ECIG use, they demonstrate a 
seemingly improved ability to extract nicotine from the device (Hajek et al., 2015). Specifically, 
following a 60-min ad lib puffing session at baseline and again at the end of 4 weeks, their peak 
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plasma nicotine concentrations increase by a 24% and their total nicotine intake increases by 
79%  (Hajek et al., 2015). Still, none of this early work measured users’ topography during ECIG 
vaping. 
Work that does include topography measurement suggests that that ECIG puffing 
behavior is comparable to cigarette puffing behavior among ECIG-naïve users (Farsalinos et al., 
2013; Hua, Yip, & Talbot, 2013), and that ECIG-naïve users puff differently than ECIG-
experienced users (Farsalinos et al., 2013; Spindle et al., 2015b). Smokers and ECIG-naïve users 
take puffs of approximately two sec in duration (Farsalinos et al., 2013). ECIG-experienced 
users, however, show puff durations that are generally twice as long (e.g., >4 sec; Farsalinos et 
al., 2013; Hua et al., 2013; Spindle et al., 2015a). Increases in ECIG puff duration are an 
effective way to increase ECIG nicotine yield (Talih et al., 2015), and may therefore provide an 
ECIG user with a way to increase nicotine delivery. ECIG users may also learn to increase the 
volume of each puff and/or lower their flow rates, relative to what is typically observed for 
cigarette smoking (Spindle et al., 2015a). The research on ECIG puff topography complements 
earlier research on differential nicotine delivery between users and requires further investigation.  
Unfortunately, this research has been hampered by the lack of standardized, validated measures 
for ECIG topography (Evans & Hoffman, 2014). 
Cigarette Topography Measurement 
An understanding of the relationship between nicotine yield and nicotine delivery for 
cigarette smoking has been facilitated by the development of topography measurement devices. 
Early measurement methods included direct observation via video recording (Blank et al., 2009; 
Frederiksen, Miller, & Peterson, 1977); pneumotachographs (recorded airflow rate to and from 
the lungs; Gust, Pickens, & Pechacek, 1983; Zacny et al., 1987); and pocket calculators 
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(Henningfield, Yingling, Griffiths, & Pickens, 1980). Unfortunately, these methods have proven 
limited in the topography parameters able to be recorded (e.g., puff volume, flow rate) and/or 
inconvenient in terms of the time and labor required for measurement (Herning et al., 1981; 
Blank et al., 2009). Most recently, flowmeter designs have been used, as they improve upon the 
limitations of previous methods (Herning et al., 1981; Puustinen, Olkkonen, Kolonen, & 
Tuomisto, 1987).   
Currently available flowmeter-based topography devices include the Clinical Research 
Support System (CReSS) desktop and portable models (Hauni Maschinenbau AG/Borgwaldt 
KC, Richmond, VA). Both of these computerized devices require that smokers take puffs from a 
mouthpiece that houses the cigarette. These devices sense the pressure drop that occurs upon 
inhalation, and then digitize the flow rates using specialized computer software. These devices 
have been shown to be objective and precise for measuring puff topography in both laboratory 
(desktop model) and naturalistic (portable model) environments (Buchhalter & Eissenberg, 2000; 
Evans et al., 2003; Lee, Malson, Waters, Moolchan, & Pickworth, 2003). Thus, these devices are 
now arguably the most widely used for cigarette topography measurement among researchers in 
the field. Similar devices are now needed for measurement of ECIG topography.  
Electronic Cigarette Puff Topography Measurement 
 The first study to measure ECIG topography relied on video recording analysis of 
YouTube videos (Hua et al., 2013). The researchers used a stopwatch to record puff duration and 
exhale duration for ECIG use within 64 videos of ECIG use and for cigarette smoking within 
nine videos. Significant differences in puff duration were found between ECIG use (4.3 sec) and 
cigarette smoking (2.4 sec). Video recordings have also been used for topography measurement 
in a laboratory setting (Farsalinos et al., 2013; St. Helen et al., 2016). One study involving a 10-
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20 min ad lib puffing bout was recorded for ECIG-experienced users using an ECIG, ECIG-
naïve cigarette smokers using an ECIG, and ECIG-naïve cigarette smokers smoking a cigarette 
(Farsalinos et al., 2013). As was observed via YouTube videos (Hua et al., 2013), puff durations 
were significantly longer for ECIG use among experienced users than for cigarette smoking (4.2 
vs. 2.3 sec). Additionally, puff durations for ECIG use among ECIG-naïve cigarette smokers (2.1 
sec) were comparable to puff durations for cigarette smoking (Hua et al., 2013). More recent 
research has found average puff durations of 3.5 sec among ECIG-experienced participants 
during a 90-min, ad lib bout (St. Helen et al., 2016). These studies provided early insights into 
ECIG topography; however, video recordings cannot capture flow rate and volume. These 
puffing parameters may be important for understanding users’ total exposure to vapor 
ingredients, as has been shown for cigarette smoking (Benowitz et al., 1986; Djordjevic et al., 
1997; Zacny et al., 1987).  
 Some researchers have attempted to use cigarette topography devices to measure ECIG 
topography. The portable cigarette topography device (CReSS Pocket) can be fitted with a 
mouthpiece adaptor to fit an ECIG (Behar, Hua, & Talbot; 2015). However, the average puff 
durations among ECIG-experienced users in this work (i.e., 2.6 sec) conflict with those observed 
in other studies (e.g., >4 sec; Farsalinos et al., 2013; Hua et al., 2013; Ramôa et al., 2015). This 
difference may be explained by several limitations noted by the researchers. Notably, e-liquid 
was pulled into the topography devices for participants who took puffs of longer durations; 
therefore, these participants were excluded from data analysis (Behar et al., 2015). Additionally, 
the portable cigarette topography device is programmed to stop recording after 43 puffs, a cutoff 
that was exceeded by 26% of participants (Behar et al., 2015). Similar equipment failures leading 
to substantial data loss have been reported in other work as well (Norton, June, & O’Connor, 
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2014). Such issues demonstrate a need for devices specifically tailored to ECIG topography 
measurement that have been properly validated. 
 A recently developed ECIG topography device, the eTop, has been used to examine 
topography among experienced ECIG users (Eissenberg, 2014; Spindle et al., 2015a). The eTop 
is a computerized desktop topography device that has been designed to be sensitive to flow rates 
as low as 2 ml/sec. Plasma nicotine levels were comparable when the ECIG was vaped via the 
eTop versus when no device was used (natural ECIG vaping). Moreover, these ECIG users 
revealed an average puff duration of 4.51 sec, an average volume of 124.56 ml, and an average 
flow rate of 27.78 ml/sec during directed bouts, and a mean puff duration of 5.29 sec, an average 
volume of 148.52, and average flow rate of 27.47 ml/sec during ad lib puffing bouts (Spindle et 
al., 2016). A similar study that used the eTop to measure ECIG-experienced puff topography 
during directed bouts found similar results, with slightly longer puffs (approximately 5 sec) and 
comparable puff volumes (Ramôa et al., 2015). This topography device has also been used to 
demonstrate differences in puff duration among ECIG-experienced and ECIG-naïve individuals 
puffing on an ECIG (Lopez et al., 2016; Ramôa et al., 2015), with ECIG-naïve cigarette smokers 
taking puffs of less than 3 sec. These puffing parameters suggest that this device may provide a 
more accurate measure of ECIG topography, relative to the cigarette devices.  
Some researchers have created new portable, computerized ECIG topography devices 
(Cunningham et al., 2016; Robinson et al., 2016) or have used ECIGs that measure topography 
(Dawkins, Kimber, Doig, Feyerabend, & Cocoran, 2016), however, these devices have not been 
validated through comparison with other topography devices. These novel measurement methods 
have yielded different results than what has been demonstrated using the eTop. For example, a 
one-week study of ECIG-experienced user’s puff topography yielded mean puff durations 
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ranging from 0.6 sec to 3.4 sec (Robinson et al., 2016), which is notably lower than values 
captured by the eTop. A similar trend was found using a different novel topography device, with 
mean puff durations just above 2 sec (Cunningham et al., 2016). However, it is not clear if 
differences between studies are a function of measurement method, the ECIG used in the study, 
participant characteristics, or other unidentified factors.  
Statement of the Problem 
 The ability to measure cigarette topography has been vital to our understanding of how 
cigarette design features play a role in user exposure to nicotine and other tobacco constituents 
(Benowitz, 2001). Thus, the application of similar methods to understand the puff topography of 
ECIG devices is warranted. Existing ECIG topography measurement devices have not been 
tested thoroughly. It is important to determine whether measurement of ECIG topography 
interferes with natural puffing behavior, as well as to determine whether these ECIG topography 
measurement methods are reliable and valid. The purpose of this study, therefore, is to compare 
ECIG puffing behavior via the ECIG topography devices and natural observation methods. 
Implications 
 An important implication of this research is to provide researchers with a tool for 
evaluating ECIG puff topography. Puff topography is a useful predictor of nicotine and toxicant 
exposure, and is essential in understanding exposure to nicotine and toxicants along with device 
characteristics (Shihadeh & Eissenberg, 2015). More specifically, ECIG topography devices will 
allow for characterization of the interaction between puff topography and ECIG device 
characteristics on nicotine and toxicant exposure. Currently, researchers are using topography 
devices that have not been validated in a rigorous manner, and are not engineered specifically to 
measure ECIG puff topography. Thus, the current project may provide a standardized tool that is 
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reliable and valid to reduce differences between studies due to use of different or inaccurate 
topography devices. In addition, future directions may allow the topography devices to be 
reduced in size to a portable device, allowing for measurement of ECIG puff topography in the 
natural environment. 
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Chapter 2 - Method 
Selection of Participants 
Participants were recruited through word-of-mouth and university-approved 
advertisements around the greater Morgantown area. Of those individuals deemed eligible, 7 
ECIG-naïve cigarette smokers and 5 ECIG-experienced users completed the study. This sample 
size is smaller than the number planned (n=20 per group) based on a power analysis using data 
from previous work that examined ECIG topography between groups with similar inclusion 
parameters (Spindle et al., 2015a). Those data revealed moderate to large effect sizes for puff 
duration and volume (Cohen’s f = 0.45 to 0.79; Cohen, 1988), the primary outcome measures to 
be examined in the current study, for between-subjects effects. Effect sizes for other outcome 
measures of interest are also moderate to large: f’s > 0.43 for subjective withdrawal effects and 
physiological parameters. Thus, the final sample was likely underpowered to detect many of the 
desired effects.  
Inclusion criteria. Inclusion criteria differed as a function of experimental group. ECIG-
naïve cigarette smokers must have reported smoking at least 10 cigarettes per day for at least one 
year (verified via expired air CO level of no less than 10 ppm; Breland, Buchhalter, Evans, & 
Eissenberg, 2002; Cobb, Weaver, & Eissenberg, 2010), no more than 5 lifetime ECIG uses, and 
no ECIG use in the past month (Cobb et al., 2010; Hajek et al., 2015; Lechner et al., 2015; 
Norton et al., 2014). ECIG-experienced users must have reported current ECIG use for at least 3 
months, use of at least 1 ml of e-liquid daily with a nicotine concentration no less than 4 mg/ml, 
and smoking no more than 5 cigarettes per day (as in Spindle et al., 2015a; Vansickel & 
Eissenberg, 2013). 
            Exclusion criteria. Individuals were excluded if they reported a history of medical or 
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psychiatric conditions, regular use of most prescription medications (e.g., excluding vitamins and 
birth control), or use of illicit substances in the past month. Women who reported current breast-
feeding or pregnancy, or tested positive for pregnancy via urinalysis, were excluded. These 
exclusionary criteria have been used successfully in similar research (Blank et al., 2009; Breland 
et al., 2002; Cobb et al., 2010; Eissenberg, Griffiths, & Stitzer, 1996; Spindle et al., 2015a). 
Telephone screening procedure. Individuals who responded to advertisements were 
screened initially via telephone interview. Laboratory staff read an approved transcript to explain 
the study requirements and procedures to interested callers. Individuals were asked to report on 
basic demographic, medical history, and drug use information (Appendix A). Individuals who 
appeared eligible based on these questionnaires were asked to visit the laboratory for an in-
person screening (as in Blank et al., 2009; Buchhalter & Eissenberg, 2000; Cobb et al., 2010; 
Evans et al., 2003).  
A total of 90 calls were received from individuals interested in study participation. Of 
these 90 calls, 66 individuals were deemed ineligible via a telephone-based screening 
questionnaire. The primary reasons for ineligibility were history of medical or psychiatric 
conditions (n=24), use of < 4 mg/ml nicotine for ECIG-experienced users (n=13), and > 5 
lifetime ECIG uses for ECIG-naïve cigarette smokers (n=20).  
Informed consent & in-person screening procedures. Individuals were guided through 
the informed consent form to demonstrate study purpose, study procedures, and the potential 
risks and benefits of participation. Those who were willing and able to consent then completed 
additional screening procedures. The laboratory screening visit consisted of questionnaires 
similar to those administered via the telephone interview (Appendices B – C). The purpose of 
these near-identical questions is to ensure reliability of reporting; individuals whose answers 
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were conflicting were disqualified from participation. Additionally, cigarette smokers completed 
the Fagerström Test of Nicotine Dependence (FTND; Appendix D) (Heatherton, Kozlowski, 
Frecker, & Fagerström, 1991), with scores of 0 – 3 for minimal dependence, 4 – 6 for moderate 
dependence, and 7 – 10 for high dependence. ECIG users completed the Penn State Electronic 
Cigarette Dependence Index (Appendix E) (Foulds et al., 2015), with scores of 0 – 3 for no 
dependence, 4 – 8 for low dependence, 9 – 12 for medium dependence, and above 13 for high 
dependence. Participants’ expired air CO level, measured via piCO+ Smokerlyzer (coVita; 
Haddonfield, NJ), was sampled to confirm current smoking status. Current cigarette smokers 
must have provided a CO level >10 ppm, while no cutoff was used for ECIG-experienced users. 
ECIG use does not cause measurable increases in expired air CO (Yan & D’Ruiz, 2015; 
Vansickel et al., 2010), thus making CO level a poor biomarker of ECIG use or abstinence. A 
trained staff member collected a urine sample from women to test for pregnancy (QuickVue, 
Quidel Corporation, San Diego, CA). Individuals who met the criteria for participation were 
scheduled for a session. 
Study Design 
This study used a mixed between-within subject design and included three Latin-square 
ordered sessions. The between-subjects factor was ECIG experience: ECIG-naïve cigarette 
smokers and ECIG-experienced users. Within-subjects factors were topography measurement 
method (eTop, eTop 2.0, and natural observation), bout (1-3), and time (pre- and post-ECIG bout 
for subjective and physiological outcomes).  
Session procedure. Participants visited the laboratory for three, approximately 2-hour 
sessions. Sessions were separated by a minimum of 48 hours to avoid carryover effects (as in 
Breland et al., 2002; Eissenberg et al.,1996; Lechner et al., 2015; Spindle et al., 2015a). 
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Participants were asked to abstain from all nicotine and tobacco products for 12 or more hours 
before a study session. Overnight abstinence was expired air CO (≤ 10 ppm; Blank et al., 2009; 
Spindle et al., 2015a; Tackett et al., 2015). The session began with continuous recording of heart 
rate and blood pressure. Thirty min later, participants completed baseline questionnaires that 
assess nicotine/tobacco withdrawal symptoms and direct nicotine effects. Next, participants were 
asked to take 10 puffs from their ECIG using a standardized puffing procedure. Specifically, 
each puff was separated by 30 sec with laboratory staff guiding the procedure (as in Vansickel et 
al., 2010; Vansickel & Eissenberg, 2013; Spindle et al., 2015a). Depending on the condition, 
participants puffed on their ECIG using the ECIG topography devices or no device (i.e., 
naturally). All sessions were videotaped. Immediately following the guided bout, participants 
again completed questionnaires that assess withdrawal symptoms and direct nicotine effects. 
This same procedure (questionnaires, ECIG use, and questionnaires) was repeated for two 
additional bouts, with 30 min separating each bout. However, for these last two bouts, 
participants were permitted to puff on their ECIG ad lib for 5 min. At the end of session, 
participants completed a final questionnaire that assessed their perceived acceptability of 
measurement method (as in Blank et al., 2009; Spindle et al., 2015a). Participants were 
compensated $50 for session 1, $75 for session 2, and $75 for session 3, totaling $200. 
Materials 
ECIG devices and e-liquid. As in previous work (Spindle et al., 2015b), all participants 
used the e-GO 3.3 V, 1000mAh battery (Joyetech; Irvine, CA) and a 510-style cartomizer with 
1.5 ohms resistance and a dual-heating coil (SmokTech; Smoke Technology Co LTD; Shenzhen 
China). Cartomizers were filled with 1 ml of e-liquid of the participants’ preferred flavor 
(tobacco or menthol), with 18 mg/ml of nicotine and a 70:30% propylene glycol:vegetable 
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glycerin ratio. This combination of device and e-liquid features is capable of delivering 
pharmacologically active doses of nicotine to both ECIG-experienced and ECIG–naïve users 
(Spindle et al., 2015b; Hiler et al., 2015). 
ECIG topography devices. The eTop and eTop 2.0 continuously monitor, digitize, and 
record the instantaneous flow rate through an ECIG. Based on the recorded signal, the devices 
compute the start and end time, and volume of every puff. A puff is detected whenever the flow 
rate exceeds a user-input threshold (which can be as low as 2 ml/sec) for a duration greater than a 
user-input minimum (e.g. 0.3 sec). The volume of a puff is computed by numerical integration of 
the flow rate versus time record of the puff using the trapezoidal rule. Based on the start and end 
time of every puff, the total number of puffs detected, and the volume of each puff detected, the 
average puff duration, interpuff interval, and puff volume are computed.  Data filtering is applied 
to the raw flow rate signal.  Non-zero flow rates occurring over a duration that is less than the 
user-input minimum are assigned a value of zero. If two or more adjacent puffs are separated in 
time by less than a user-input threshold (0.3 sec), they are treated as a single continuous puff. 
Video equipment. A Canon Vixia HF R42 (Canon USA, Inc.; Melville, NY) was used to 
record ECIG use within all conditions. This camera model was chosen based on its video quality, 
Wi-Fi capabilities, and size. The DIGIC DV 4 Image Processor improves noise-reduction in an 
image and image clarity in poorly light rooms. Additionally, the small size of the camera may 
reduce potential effects of observation on smoking behavior. The video data were imported to 
Adobe Premier Pro 2015 (Adobe Systems, Inc.; San Jose, CA), and analyzed using frame-by-
frame time analysis. These methods were used in a similar study comparing cigarette topography 
devices and natural observation (Blank et al., 2009). 
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Primary Outcome Measures  
Puff topography. Puff topography variables, as measured by the ECIG topography 
devices, included puff number (puff count per cigarette), duration (measured in sec), volume 
(measured in ml), IPI (measured in sec), and flow rate (measured in ml/sec). These devices 
generate a puff at a flow rate greater than 2 ml/sec; thus, the start of a puff is registered when the 
flow rate reaches 2 ml/sec and ends when the flow rates returns below 2 ml/sec. Video 
recordings were used to measure puff number, duration, and IPI, but could not capture puff 
volume or flow rate. However, puff duration and volume are highly correlated measures (Evans 
et al., 2003; Gust et al., 1983), and puff duration measurement via video recordings has been 
used successfully in the past to demonstrate well-established smoking behaviors (Blank et al., 
2009; Frederiksen et al., 1977).  
Before choosing the final operational definitions for ECIG puffing behaviors, data from 
several pilot subjects were scored. A puff was counted each time the ECIG (eTop 2.0 and video 
conditions) or mouthpiece (eTop) was brought to the user’s lips, and number was the total 
number of puffs > 300 milliseconds within an ECIG bout. Puff duration was defined as the time 
from the onset to the offset of a single puff, while IPI was defined as the time from the offset of 
one puff to the onset of the next puff. For these latter two puff topography variables, two 
different operational definitions were considered: “lip” definition and “light” definition. These 
definitions differed by the frame (i.e., akin to a still image) chosen for puff onset, as well as that 
chosen for puff offset. The “lip” definition used the first frame in which the lips were enclosed 
around an ECIG or topography mouthpiece as puff onset, and the last frame in which the lips 
were enclosed around the ECIG or mouthpiece as puff offset (i.e., the frame immediately prior to 
that showing removal of the ECIG/mouthpiece). A similar lip-based definition has been used for 
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other video-scored topography for cigarettes (Blank et al., 2009) and ECIGs (Farsalinos et al., 
2013; Nides, Leischow, & Rabinowitz, 2015; St. Helen et al., 2016). The “light” definition used 
the first frame in which the LED light on the ECIG battery was glowing (indicating that the 
button had been pressed to active the atomizer) for puff onset, and the last frame in which the 
LED light remained glowing for puff offset (i.e., the frame immediately prior to that showing 
that the LED light was no longer glowing). The data captured using video recordings were 
scored by two independent raters and then compared for reliability (as in Blank et al., 2009; 
Frederiksen et al., 1977; Lichtenstein & Antonuccio, 1981), with a minimum cutoff of r > 0.90. 
Acceptability questionnaire. An acceptability questionnaire (Appendix F) was 
administered to assess participants’ subjective experience of how the measurement method used 
“altered smoking behavior,” “made smoking less likely,” “reduced smoking enjoyment,” 
“affected the taste of the cigarettes,” “made smoking more difficult,” and “increased awareness 
of how much was smoked” (Blank et al., 2009). All items were presented as a VAS with scores 
that range from 0 to 100. This set of questions has been used in previous work that involved 
comparison of methods to measure cigarette topography (Blank et al., 2009) and ECIG 
topography (Spindle et al., 2015a). 
Secondary Outcome Measures  
Hughes and Hatsukami questionnaire. The Hughes and Hatsukami (1986) 
questionnaire (Appendix G) is a measure of nicotine/tobacco withdrawal symptoms with 11 
items: “Urges to smoke”, “Irritability/frustration/anger”, “Anxious”, “Difficulty concentrating”, 
Restlessness”, “Hunger”, Impatient”, “Craving a cigarette/nicotine”, “Drowsiness”, 
“Depression/feeling blue”, and “Desire for sweets”. Participants were shown the word or phrase 
centered above a horizontal line serving as a visual analog scale (VAS). The left end of the line 
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will show the phrase “not at all” (score = 0), and the right end will show the phrase “extremely” 
(score = 100). Participants moved the cursor to any point of the line and clicked to create a 
vertical mark, which could be moved before the participant continued to the next question. Each 
score was expressed as a percentage of the total line length from the left end to the vertical mark. 
Internal consistency for this measurement is not assessed, however, the items are known to be 
valid and reliable indicators of withdrawal symptoms (Hughes & Hatsukami, 1986; Hughes, 
2007). This questionnaire is commonly used assess withdrawal symptoms in cigarette smokers 
(Blank et al., 2009; Nides et al., 2014; Spindle et al., 2015a; Wagener et al., 2014). 
Tiffany-Drobes Questionnaire of Smoking Urges (QSU): Brief Form. The Tiffany-
Drobes QSU: Brief Form (Appendix H; Cox et al., 2001; Tiffany & Drobes, 1991) consists of 10 
Likert-scale items measuring multidimensional features of nicotine/tobacco cravings. Statements 
(e.g., “All I want right now is a cigarette”; “I am going to smoke as soon as possible”) will be 
presented above seven boxes, with the leftmost labeled “strongly disagree” (score = 0) and 
rightmost labeled “strongly agree” (score = 6). Participants moved the cursor to select one box, 
which could be adjusted before continuing to the next item. Statements for ECIG-experienced 
participants were adapted by replacing “cigarette” and “smoke” with “ECIG” and “vape”, 
respectively. Items were collapsed into two factors previously defined by factor analysis: 
intention to smoke and anticipation of relief from withdrawal. The QSU has demonstrated high 
reliability (Cronbach’s alpha = 0.97; Cox et al., 2001) and internal consistency within each of the 
two factors (Cronbach’s alpha = 0.96, 0.92; Cox et al., 2001). The QSU is a common measure of 
nicotine/tobacco withdrawal symptoms (Blank et al., 2009; Blank et al, 2011; Norton et al., 
2014; Vansickel & Eissenberg, 2013). 
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Direct Effects of Nicotine Scale (DENS). The DENS (Appendix I; Evans, Blank, Sams, 
Weaver, & Eissenberg, 2006) consists of 10 VAS items to assess the severity of nicotine-
associated side effects: “nauseous,” “dizzy,” “lightheaded,” “nervous,” “sweaty,” “headache,” 
“excessive salivation,” “heart pounding,” “confused,” and “weak.”  
Direct Effects of ECIG Use. The Direct Effects of ECIG Use (Appendix J; Foulds et al., 
1992; Pickworth, Bunker, & Henningfield, 1994) consists of 9 VAS items to assess effects 
commonly reported with cigarette smoking, but items are modified to ask about vaping (e.g. 
“Was the ECIG satisfying?” and “Did the ECIG help you concentrate?”) (Blank et al., 2011; 
Spindle et al., 2015a; Vansickel et al., 2010).  
Physiological measures. Heart rate and blood pressure were measured continuously 
throughout each session (Noninvasive Patient Monitor model 506 NP3, Criticare Systems, Inc., 
Waukesha, WI). Data were collected every 20 sec for heart rate and every 5 min for blood 
pressure, and then transferred to a computer. Data for heart rate were averaged into 5-min bins to 
create a single value pre- and post-vaping for each ECIG bout. The purpose for measurement of 
these physiological parameters was twofold. First, both heart rate and blood pressure are 
indicative of exposure to nicotine (Jolma, Samson, Klewer, Donnerstein, & Goldberg, 2002; 
Omvik, 1996). Second, heart rate and blood pressure were used to monitor participant safety, and 
a medical monitor was contacted if a participant’s vital signs fell out of a predetermined range 
(see subsection Participant Safety and Rights). These materials and methods for collected 
physiological data have been used in similar work (Blank et al., 2009; Breland et al., 2002; 
Evans et al., 2006; Spindle et al., 2015a). 
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Participant Safety and Rights 
 Participants’ safety and rights were assured through an IRB-approved protocol enacted 
by trained laboratory staff. Participants were made aware of the Office of Research Integrity and 
Compliance and the fact that they could contact this office with questions about their rights as 
participants. Although acute use of an ECIG was expected to incur no adverse events, individuals 
were informed of the potential risks. For example, participants were informed of the ingredients 
of the e-liquid in case they have any known allergies to such ingredients. Participants were also 
warned that they may experience aversive withdrawal symptoms from tobacco abstinence such 
as irritability, anxiety, and restlessness (Hughes & Hatsukami, 1986; Rubinstein et al., 2009). 
These effects may cause discomfort; however, they are not medically dangerous. To ensure 
safety during ECIG use, physiological measures were monitored continuously. A medical 
monitor was contacted regarding participant safety if heart rate falls out of the range of 50 to 110 
bpm, systolic blood pressure out of the range of 90 to 150, and diastolic pressure out of the range 
of 60 to 100.  Confidentiality was assured by using coded identity numbers for participant data 
and storing data in locked rooms and on password protected computers.  
Data Preparation and Analysis 
Data Preparation. Prior to data analyses, puff topography data collected via the 
computerized devices were cleaned by an automated procedure. First, all consecutive puffs 
separated by less than 300 ms were combined into a single puff. Next, any remaining single puffs 
shorter than 300 ms were considered artifacts and thus deleted (as in Spindle et al., 2016). For 
puff topography data collected via video recordings, this cleanup procedure was manually 
applied to the values averaged between the two independent raters. Puff topography values 
within each bout were averaged across puffs to create a single value for puff duration, IPI, puff 
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volume, and flow rate (Blank et al., 2009; Spindle et al., 2016). Thus, three values (one for 
directed and two for ad lib) for these topography variables were produced for each measurement 
method. Heart rate values were averaged into 5-min bins to create a single value for pre- and 
post- for each bout (Vansickel et al., 2012; Vansickel et al., 2010).  
Data Analyses. Due to the small sample sizes for both groups (n=7 and 5 for ECIG-
experienced and -naïve users, respectively), descriptive statistics and planned comparisons were 
conducted. Comparisons were chosen based on a combination of published literature suggesting 
a reliable effect and/or known effect sizes for a given outcome measure. Puff number, duration, 
and IPI were compared between the measurement methods (eTop, eTop 2.0, and video) using 
paired samples t-tests. The outcome measures of puff volume and flow rate were not included in 
these analyses because these topography parameters are not able to be measured by video alone. 
Puff duration was also compared between ECIG-experienced and ECIG-naïve participants using 
an independent samples t-test (Farsalinos et al., 2013, Lopez et al., 2016; Ramôa et al., 2015). 
Select subjective and physiological outcomes were compared between timepoints using paired 
samples t-tests. The subjective items chosen included “Urges,” “Craving”, and 
“Irritability/Frustration/Anger,” from the Hughes-Hatsukami questionnaire (Spindle et al., 2016; 
Vansickel et al., 2010; Vansickel et al., 2012). Also analyzed were Factor 1 and Factor 2 scores 
of the Tiffany-Drobes QSU (St. Helen et al., 2016; Vansickel et al., 2012; Vansickel et al., 
2010), as well as the items “Satisfying,” “Pleasant,” and “Tastes Good” for the Direct Effects of 
ECIG Use (Spindle et al., 2016; Vansickel et al., 2012; Vansickel et al., 2010). Heart rate was the 
only physiological outcome analyzed (Nides et al., 2014; Vansickel et al., 2012; Vaniskcel et al., 
2010). All subjective and physiological items were compared between baseline and post-directed 
bout, as well as between baseline and the first post-ad lib bout. Previous work has demonstrated 
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differences between these timepoints for ECIG-related withdrawal suppression (Dawkins & 
Cocoran, 2014; Spindle et al., 2016; St. Helen et al., 2016), and increased ratings of product 
effects (Spindle et al., 2016; Vansickel et al., 2010; Vansickel et al., 2013). 
To correct for multiple comparisons, the False Discovery Rate (FDR) procedure was used 
(Benjamini & Hochberg, 1995). This procedure reduces the likelihood of making a Type I error 
by controlling for the expected proportion of false positives out of all rejected null hypotheses. 
The FDR procedure was chosen because it provides increased power to detect significant 
differences as compared to more classical approaches such as the Bonferroni correction, thus 
reducing the likelihood of a Type II error (Benjamini & Hochberg, 1995). The FDR procedure 
involves the ranking of all statistical tests followed by the determination of a new, individual 
critical value for each test. Thus, the FDR procedure avoids the problem of ambiguity in defining 
a “family” of statistical tests. Note that all t-tests observed to be significant remained significant 
after applying the FDR. 
The Pearson Correlation Coefficient (r) (p’s < .05) was used for all correlation analyses 
described below except interrater reliability for puff number. This latter comparison was made 
using an Intraclass Correlation (ICC; Shrout & Fleiss, 1979), which assesses absolute agreement 
between raters. Interrater reliability was assessed by correlating puff number, duration, and IPI 
for each bout for both the lip and light definition. A minimum cutoff of r > .90 was used to 
determine if the two raters were reliable. To determine the relationship between the video and 
computerized device methods, video scores of puffing via computerized device (eTop or eTop 
2.0) or naturally (video) were correlated with scores generated by each computerized device 
(eTop or eTop 2.0). These correlations were conducted for both the lip and light definitions of 
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puff topography derived from the video recordings. To assess reliability of each measurement 
method, puff topography for the two ad lib bouts within a session were correlated.  
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Chapter 3 - Results 
Demographics 
 Table 1 displays demographic characteristics for the full sample, as well as for ECIG-
experienced and ECIG-naïve participants separately. All participants were male and non-
Hispanic, and the large majority were White with at least a high school degree. Scores on the 
respective dependence scale suggested that ECIG-experienced participants were moderately 
dependent, and ECIG-naïve participants were low to moderately dependent, on their product of 
choice. Importantly, groups did not differ significantly on age, t(10) = 0.26, p > .05, years of 
education, t(10) = -1.13, p > .05, or racial category, x2 (1) = 0.07, p > .05. Statistical tests were 
not conducted for gender or ethnic category because all participants were male and non-
Hispanic. 
Interrater Reliability 
Table 2 shows that while all topography values were correlated significantly between 
raters (all p’s < .05), the criterion of r > .90 was not met for two values using the lip definition 
and for three values using the light definition. Overall, a higher number of puffs were identified 
using the lip definition than the light definition. For the directed bout (collapsed across group and 
device), which was set at 10 puffs, the average (±SD) number of puffs counted using the lip 
definition was 10.0 ± 0.42 (range = 9-11; mode = 10; median = 10) and 10.2 ± 0.52 (range = 9-
12; mode = 10; median = 10) for the two raters, respectively. For this same bout (collapsed 
across group and device), the average number of puffs counted using the light definition was 5.7 
± 3.8 (range = 0-10; mode = 10; median = 6) and 7.6 ± 3.3 (range = 0-11; mode = 10; median = 
9) for the two raters, respectively. This same pattern was observed for the ad lib bouts, with the 
lip definition identifying more puffs than the light definition for the same puffing bout. 
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Effects of Measurement Method 
Table 3 displays descriptive statistics for all topography variables for each measurement 
method, and correlations coefficients for comparisons between measurement methods, collapsed 
across group and bout. All comparisons that included data from the video condition were based 
on the lip definition, as this definition was assumed to more accurately reflect ECIG puffing 
based on the descriptive statistics for the directed bout. No significant differences between 
measurement methods were observed (all p’s > 0.05). 
Correlation coefficients for comparisons between data collected via computerized 
topography devices (i.e., eTop and eTop 2.0 conditions) and via video when no topography 
device was used (i.e, natural observation condition) are displayed in Table 4. For puff duration, 
correlations were largely significant between the computerized topography devices and video 
methods (most r’s > 0.26, p’s < 0.05). For puff number and IPI, however, only nine and eight of 
24 possible comparisons attained significance (most r’s < 0.42; p’s > 0.05). Overall, of the 36 
comparisons made using each definition, 58.3% were observed to be significant for the lip 
definition and 44.4% were observed to be significant for the light definition. Also notable is that 
5.6 % of puffs identified by the eTop and 4.8 % of puffs identified by the eTop 2.0 were not 
identified by video alone when the lip definition was used. In contrast, 37.6 % of puffs identified 
by the eTop and 33.3 % of puffs identified by the eTop 2.0 were not identified by video alone 
when the light definition was used. 
 Table 5 displays correlations between data collected by computerized topography devices 
(i.e., eTop and eTop 2.0) and by video recordings of computerized topography device use (i.e., 
videos of eTop and eTop 2.0). Correlation coefficients attained significance for all comparisons 
for puff duration (r’s > 0.47, p’s < .01), and for most comparisons for IPI (most r’s > 0.35, p’s > 
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.05), for both operational definitions. For puff number, however, only nine of 24 possible 
comparisons were observed to be significant (most r’s < 0.88, p’s > 0.05).  
 There was a significant correlation between the ad lib bouts within each measurement 
method for puff duration for the eTop 2.0 (r = .46, p < .01), eTop (r = .59, p < .01), and video 
using the lip definition (r = .56, p < .01) and light definition (r = .49, p < .01). There was a 
significant correlation between the ad lib bouts within each measurement for puff number for the 
eTop 2.0 (r = 0.83, p < 0.01), eTop (r = 0.95, p < 0.01), and video using the lip definition (r = 
0.95, p < 0.01), and light definition (r = 0.87, p < 0.01). For IPI, there was a significant 
correlation between the ad lib bouts within each measurement for the eTop 2.0 (r = 0.54, p < 
0.01), and video using the lip definition (r = 0.52, p < 0.01) and light definition (r = 0.34, p < 
0.05), but not for the eTop (r = 0.02, p > 0.05). 
Effects of ECIG-Experience 
Table 6 shows means (±SEMs) for all topography outcomes for group by bout. An 
independent samples t-test revealed that puff duration did not differ significantly between 
groups; collapsed across device and bout, the average puff duration for ECIG-experienced 
cigarette smokers was 3.68 ± 0.49 sec and for ECIG-naïve users was 4.05 ± 0.89 sec (t(65) = 
1.08, p > .05). 
Acceptability 
  Table 7 displays the means and standard deviations for acceptability questionnaire items 
for each device, separated by group. No comparisons were conducted for any of these items. 
Hughes-Hatsukami Questionnaire 
 Table 8 displays means and standard errors for the selected subjective and physiological 
outcomes at baseline, post-directed bout, and post-ad lib 1. For the Hughes-Hatsukami item 
“Urges”, significant differences were observed from baseline to post-directed bout, t(35) = 4.33, 
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p < .001, and from baseline to post-ad lib 1, t(35) = 5.94, p < .001. As is apparent from the table, 
scores for this item decreased significantly from baseline to post-ECIG puffing at each timepoint. 
Similarly, for “Irritability/Frustration/Anger” scores were also decreased significantly from 
baseline to post-directed, t(35) = 4.11, p = .001, and from baseline to post-ad lib 1, t(35) = 4.37, 
p < .001. Finally, scores for “Craving” were significantly lower at post-directed, t(35) = 5.46, p < 
.001, and post-ad lib 1, t(35) = 5.86, p < .001, timepoints relative to baseline. 
Tiffany-Drobes QSU 
 For the Tiffany-Drobes QSU, a significant difference in Factor 1 scores (possible range 0 
– 30) between baseline and post-directed bout, t(35) = 5.93, p < .001, as well as between baseline 
and post-ad lib 1, t(35) = 6.00, p < .001, was observed. Similar findings were revealed for Factor 
2 (possible range 0 – 24) between baseline and post-directed bout, t(35) = 4.31, p < .001, and 
between baseline and post-ad lib 1, t(35) = 4.87, p < .001. For both Factor 1 and Factor 2, ratings 
were higher at baseline than the post-ECIG puffing timepoints. 
Direct Effects of ECIG Use 
 For the measure Direct Effects of ECIG Use, ratings of “Satisfying” were significantly 
lower at baseline than at the post-directed, t(35) = -5.27, p < .001, and post-ad lib 1, t(35) = -
5.27, p < .001, timepoints. Significantly lower ratings of “Pleasant” at baseline, relative to post-
directed, t(35) = -4.88, p < .001, and post-ad lib 1, t(35) = -4.72, p < .001, timepoints was also 
observed. Additionally, ratings of “Taste Good” were significantly different between baseline 
and post-directed, t(35) = -2.98, p < .01, and from baseline to post-ad lib 1, t(35) = -3.39, p < .01, 
with lower scores at baseline than the post-ECIG puffing timepoints. 
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Heart Rate 
 Heart rate increased significantly from baseline to post-directed bout, t(32) = -5.48, p < 
.001, as well as from baseline to post-ad lib 1, t(30) = -2.61, p < .05. 
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Chapter 4 - Discussion 
Puff topography offers an objective measure of nicotine self-administration in humans. 
For instance, this measure has been instrumental in predicting nicotine and toxicant delivered 
from cigarettes to the user (Sutton et al., 1982; Zacny et al., 1987), as well as how user behavior 
can change in response to differences in cigarette characteristics (Herning et al., 1981; Zacny & 
Stitzer, 1988). Consequently, researchers are interested in using puff topography measurement to 
examine the interaction between user behavior and product characteristics for ECIGs. The ability 
to measure puff topography is facilitated by the use of computerized devices; however, available 
commercialized devices were designed to measure cigarette puff topography (Buchhalter & 
Eissenberg, 2000; Lee et al., 2003; Blank et al., 2009) and thus may not measure ECIG puffing 
accurately or reliably. Moreover, devices designed specifically to measure ECIG puff 
topography, either in the laboratory (Lopez et al., 2016; Ramôa et al., 2015; Spindle et al., 2016) 
or in the natural environment (Cunningham et al., 2016; Robinson et al., 2015; Robinson et al., 
2016), have yet to be tested systematically. The current project was designed to compare the 
reliability and validity of two different ECIG-based computerized topography devices with 
natural observation.  
Video-Based Topography Measurement 
 Two different operational definitions, one lip-based and one light-based, for puff 
topography outcomes were considered for the natural observation (i.e., video-alone) condition. 
The reliability criterion was met for more lip-based than light-based scores (7 versus 6, 
respectively), and raters’ number of puffs scored for each bout using the lip-based definition 
more closely aligned with the number of puffs set for the directed bout (e.g., 10 puffs). 
Additionally, when puff topography scores were compared between those derived from the 
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computerized devices (i.e., eTop and eTop 2.0) and those derived from video recordings of the 
devices in use, use of the lip-based definition resulted in less missing data. For example, for the 
directed bout, the lip-based definition missed 1.5% of puffs scored by the eTop 2.0 and the light-
based definition missed 21.2% of these puffs. Similarly, for the directed bout, the lip-based 
definition was missing 3.2% of puffs scored by the eTop and the light-based definition was 
missing 38.6% of these puffs. The relatively large amount of missing data based on the light 
definition may be due to several factors. First, participants may have pressed the button to 
activate the atomizer as they were lifting the ECIG to their lips, and before the ECIG was within 
the view of the video camera. Second, participants may have held their ECIG in such a way that 
the button was facing away from the camera lens. Finally, participants may have covered the 
button entirely with their finger. Instructions to participants on how to use their ECIG might 
resolve these issues, but of course would interfere with natural puffing behavior. Consequently, 
use of the lip-based definition likely offers a more accurate measure of ECIG puff topography 
than light-based measures.  
Comparisons of Topography Measurement Methods 
 Puff number, duration, and IPI did not differ significantly between measurement 
methods, similar to what has been reported when computerized devices are compared to natural 
observation for measurement of cigarette smoking topography (Blank et al., 2009). While this 
finding may imply that all three measurement methods were capturing topography similarly, it is 
also possible that the sample size was too small to detect meaningful differences between the 
measurement methods. The relatively small sample size may also have influenced the observed 
correlations between topography as measured via the computerized devices versus that measured 
via natural observation methods. Most scores for puff duration, but not number or IPI, were 
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significantly correlated between methods when examined as a function of group and bout. These 
differences may be explained by either the manner in which the devices measure topography or 
the manner in which users puff on an ECIG when using the devices. The former factor may 
involve instances of “double puffing,” in which an individual takes multiple short puffs in quick 
succession without fully removing the ECIG or eTop mouthpiece from their lips. In these cases, 
video-based measurement may identify a single puff while computerized device-based 
measurement may identify more than one puff. That is, the device may be more sensitive to 
changes in pressure that occur when users change their pattern of inhalation while the ECIG is in 
their mouth. Consequently, puff duration and IPI measures will be affected. At least based on 
this current study, the behavior of “double puffing” appears to occur more often for ECIG 
puffing than cigarette puffing (Blank et al., 2009). It is also possible that the automated clean-up 
procedure used to identify and eliminate artifacts generated by the computerized topography 
devices may have affected topography indices. Regarding the latter issue, users may of course 
simply puff differently when they use a computerized topography device versus when they puff 
directly from the ECIG. One of the computerized topography devices relies on an additional 
mouthpiece (i.e., the eTop) and both devices rely on plastic tubing to measure topography. These 
device features may have influenced the manner in which an ECIG is held and/or the manner in 
which the ECIG is placed in the mouth. Future work will need to include larger sample sizes to 
examine differences between these topography outcomes, as well as between puff volumes and 
flow rates for the eTop 2.0 and eTop computerized devices. 
 Cross-study comparisons suggest that the average topography scores observed here do 
not correspond to those observed in other work, even when participants take 10 puffs from the 
same ECIG model (e.g., e-GO battery, 510 cartomizer) using the eTop device. For instance, 
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longer average puff durations (4.51 - 4.97 sec), larger average puff volumes (114.7 - 124.6 ml), 
and higher average flow rates (23.3 - 27.78 ml/sec) have been reported for ECIG-experienced 
users (Ramôa et al., 2015; Spindle et al., 2016). Similarly, shorter average puff durations (2.85 
sec) and smaller average puff volumes (70.2 ml) have been reported for ECIG-naïve cigarette 
smokers (Lopez et al., 2016). In this other work, however, ECIG-experienced users reported use 
of a higher nicotine concentration (18.9 mg/ml -19.8 mg/ml) and less volume of ECIG liquid per 
day (2.0 – 2.7 ml), while ECIG-naïve cigarette smokers reported smoking for longer (average = 
10 years), as compared to participants in the current study (Lopez et al., 2016; Ramôa et al., 
2015; Spindle et al., 2016). These participant characteristics may account for some of the 
differences noted here. 
Overall, ECIG puff topography was measured by the computerized devices precisely as 
was measured by the video recordings of use of these same computerized devices. Specifically, 
correlations between these measurements as a function of group and bout were largely 
significant (r’s ranged from 0.47 to 1.0, p’s < 0.05). Still, some correlations for puff number, 
particularly for ECIG-naïve participants, were not significant. Importantly, all methods measured 
topography reliably, as evidenced by the significant correlations for most topography indices 
between ad lib bouts within a condition. Still, these correlation coefficients (r) were no higher 
than 0.59, and lower than what has been reported for cigarette topography (r’s > 0.69, Blank et 
al., 2009). Notable is that cigarette puffing topography for dependent cigarette smokers has 
shown to be a well-established behavior in that puffing is consistent within and across cigarettes 
(Lee et al., 2003; Perkins, Karelitz, Giedgowd, and Conklin, 2012). In the current study, ECIG-
naïve cigarette smokers reported no more than 5 ECIG uses in their lifetime (M = 2.6, SD = 
1.95), and thus were puffing on an unfamiliar product. The ECIG experienced users reported use 
MEASUREMENT OF ELECTRONIC CIGARETTE TOPOGRAPHY 37  
of their ECIG for an average of only 1.96 years, and also may have been puffing on an ECIG 
device different from their usual model. Specifically, four of seven ECIG-experienced users were 
using third-generation devices, which are more advanced models than the ECIG model used in 
this study. Additionally, for the three participants that reported using a second-generation device, 
that device had a higher power output than the ECIG model used in this study. Finally, all of the 
ECIG users reported a preference for sweet or fruit flavored (e.g., strawberry vanilla, custard, 
sweet tart) liquid, while the liquid used in the current study was unflavored. These differences in 
ECIG device and liquid features may have influenced natural puffing among ECIG-experienced 
users.  
ECIG Experience-Induced Effects 
 Average puff duration did not differ significantly between ECIG-experienced users (3.68 
sec) and ECIG-naïve cigarette smokers (4.05 sec). For the ECIG-experienced users, this 
observed value is consistent with some literature (e.g., average puff durations 3.5–3.84 sec; 
Dawkins et al., 2016; Robinson et al., 2015; St Helen et al., 2016), but lower than that reported in 
other literature (e.g., average puff durations 4.2-5.29 sec; Farsalinos et al., 2013; Ramôa et al., 
2015; Spindle et al., 2016). For the ECIG-naïve cigarette smokers, the observed value is notably 
greater than that reported previously for this population (e.g., average puff durations 2.4-3.0 sec; 
Farsalinos et al., 2013; Lopez et al., 2016, Norton et al., 2014). Differences between studies may 
be due to a variety of factors, including the device used to measure topography, the type of ECIG 
device used, the cigarette or ECIG use history characteristics of the participants, or pre-session 
nicotine/tobacco abstinence. Regarding this latter factor, participants in this study were required 
to abstain from all nicotine/tobacco products for > 12 hours prior to a session. Unfortunately, this 
requirement could be verified only in the ECIG-naïve cigarette smokers, at least based on the 
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biological fluid chosen to detect recent product use. Specifically, expired air CO provides a 
measure of exposure to tobacco products that are combusted (e.g., cigarettes), but not products 
that are aerosolized (e.g., ECIGs). The testing of other biological fluids, however, was not 
possible. Urinary or salivary cotinine, a metabolite of nicotine, has a half-life of approximately 
17 hours (Jarvis, Russel, Benowitz, & Feyerabend, 1988), and thus is not a sensitive measure of 
short-term cigarette or ECIG abstinence. Nicotine can be measured in blood plasma, and has a 
half-life of only approximately 2 hours (Benowitz, 2009). Still, the testing of plasma nicotine 
requires specialized equipment and expertise that was not available for immediate use to confirm 
abstinence. For these reasons, it is unknown whether the ECIG-experienced users who completed 
the current study complied with the overnight abstinence requirement. ECIG-experienced users 
who were nicotine satiated may have puffed differently than if they were nicotine abstinent, as 
has been demonstrated for cigarette puffing topography as a function of time since last cigarette 
(Fant, Schuh, & Stitzer, 1995). Of course, findings may also be due to the relatively small 
sample size (n=5), and thus outliers. Average puff durations for the ECIG-naïve cigarette 
smokers included here ranged from 1.70 sec to 6.66 sec. It appears that an average puff duration 
of 6.66 sec is more than double the mean for ECIG-naïve participants in the literature (Farsalinos 
et al., 2013; Lopez et al., 2016; Norton et al., 2014).  
Subjective and Physiological Response 
 
 In this study, ECIG use reliably suppressed a variety of withdrawal symptoms, as has 
been reported for both ECIG-experienced users and ECIG-naïve cigarette smokers (Dawkins & 
Cocoran, 2014; Spindle et al., 2016; Vansickel et al., 2012; Vansickel et al., 2010). Specifically, 
scores on items such as “Irritability/Frustration/Anger” and “Craving” were decreased 
significantly from pre- to post-ECIG use. ECIG use also reliably increased ratings on items 
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indicative of positive effects of ECIG use (e.g., “satisfying,” “pleasant,” and “tastes good”), as 
well as increased heart rate. These effects are also are consistent with what has been reported in 
the literature for both ECIG-experienced users and ECIG-naïve cigarette smokers (Spindle et al., 
2016; Vansickel et al., 2012l Vansickel et al., 2010). This pattern of results may indicate that the 
ECIG effectively delivered nicotine to the user. Indeed, previous work has shown the delivery of 
cigarette-like nicotine concentrations with relatively short puffing bouts with the same ECIG 
device as used in the current study has shown (Lopez et al., 2016; Spindle et al., 2016; Ramôa et 
al., 2015). Alternatively, this pattern of results may be due to learning, or exposure to cues that 
are shared between cigarettes and ECIGs. ECIGs and cigarettes may share similar form and 
function, as well as similar user behaviors such as hand to mouth movements and inhalation and 
exhalation behaviors, that may serve as similar cues between the two products (King et al., 
2016).  
Strengths 
Multiple features of the experimental design add validity to the current study as 
compared to other research using ECIG topography devices. First, the current study employed a 
rigorous method to validate the topography measurement methods. For example, the current 
study made comparison between two different topography devices, along with natural puffing 
observed by video recording. This design has been used to validate cigarette topography 
measurement methods (Blank et al., 2009), but has not been used in any ECIG topography 
research. Additionally, the exploration of two definitions for video scored puff topography 
provide reasoning for the use of the “lip” definition when evaluating topography by this method.  
Another strength of the current study is the use of both directed and ad lib bouts. Using a 
standardized, 10-puff directed bout with 30 sec IPIs is common in topography research and 
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allows for direct comparisons across studies (Lopez et al., 2016; Ramôa et al., 2015; Spindle et 
al., 2016). The use of ad lib bouts is also advantageous as it provides insight on ECIG puffing 
behavior that is more representative of natural or typical use. Finally, a value of the current study 
was the use of a standardized ECIG across all participants, in attempts to reduce variability 
associated with different ECIG designs and personal preferences.  
Limitations 
 Study outcomes may have been affected by several limitations. First, the targeted sample 
size was not reached due to delays in grant funding and the termination of the funding period 
before the full sample was completed. The final sample size of 12 is much smaller than the 
planned size of 40, and thus power to detect differences between variables was reduced.  
Consequently, Type II error (β), or the likelihood of failing to the reject the null hypothesis when 
it is false (Cohen, 1988), was likely inflated. The observed effect sizes for device comparisons 
for the primary outcomes, puff number (partial ƞ2 = 0.06), puff duration (partial ƞ2 = 0.12), and 
IPI (partial ƞ2 = 0.14), were small, and the observed power for these tests ranged from 0.06 – 
0.23. Thus, due to the combination of small effect sizes and a small sample size, the likelihood of 
making a Type II error was high. Additionally, the likelihood of making a Type I error (α) was 
likely increased due to the many comparisons that were conducted (i.e., 30 t-tests). Type I error 
is the probability of rejecting the null hypothesis when it is true (Cohen, 1988). In an attempt to 
control the Type I error rate, the FDR was employed. Specifically, this procedure involves the 
determination of a new critical value for each statistical test conducted, based on the total 
number of tests being conducted (Benjamini & Hochberg, 1995). Still, this approach is not as 
conservative as others such as the Bonferroni correction.  
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A second limitation is the inability to verify abstinence in ECIG-experienced participants, 
as mentioned previously. Indeed, this challenge has been highlighted recently in work by our 
laboratory (Blank et al., 2016). For example, differences have been observed between ECIG-
experienced users and ECIG-naïve cigarette smokers when CO and plasma nicotine levels are 
used to verify product abstinence (Lopez et al., 2016; Ramôa et al., 2015). Specifically, ECIG-
naïve cigarette smokers reveal both a low CO concentration (e.g., 6.7 ppm) and a low plasma 
nicotine concentration (3.3 ng/ml) in response to an overnight abstinence requirement. In 
contrast, ECIG-experienced users reveal a lower CO concentration of 3.0 ppm, but a higher 
plasma nicotine concentration of 5.8 ng/ml. Thus, the requirement of abstinence would be met by 
both groups using the expired air CO measure, but not the plasma nicotine measure. Rather, a 
plasma nicotine concentration of 5.8 ng/ml suggests that the ECIG-experienced users were not 
actually abstinent from nicotine. Thus, the issue of abstinence from ECIG use is a problem that 
plagues ECIG research at-large, and may contribute to the differences in results between studies. 
A third limitation is that results may not generalize to ECIG use in a natural environment, 
as ECIG use was measured in a laboratory environment. Little is known about natural ECIG 
puffing behavior, and it is possible that 5-min ad lib bouts are not long enough to simulate a 
typical ECIG-use session. Particularly, it is difficult to define a “single ECIG use episode”, as 
ECIG-experienced users may use their ECIG constantly throughout the day, as well as use 
multiple device types (Blank et al., 2016). One study found that multiple ECIG-experienced 
users engaged in puffing bouts that lasted less than 20 sec and included three or fewer puffs, 
while other ECIG-experienced users engaged in puffing bouts that were over six min and 
involved 12 or more puffs (Robinson et al., 2016). Additionally, some ECIG-experienced users 
grouped multiple puffs together with short IPIs, and separated these groupings by a longer IPI, 
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while other ECIG-experienced users spread puffs more evenly across a bout. This pattern is 
different from that observed for cigarette smoking where a bout (i.e., one cigarette) is easily 
defined.  
 A final limitation involved multiple difficulties incurred regarding the measurement of 
puff topography. First, results from initial participants indicated that the eTop 2.0 device made 
puffing more difficult, potentially by inhibiting flow rates. Thus, the device needed to be altered 
(i.e., flow collar was altered to allow more air flow in) to attempt to adjust for this interference 
with natural puffing. Additionally, calibration procedures of the topography devices were not 
fully consistent throughout the study, adding the potential for an unexpected source of error into 
topography measurement. Finally, there were multiple instances in which the topography device 
was known to be incorrect. For example, during the directed bout (30 sec IPI), there was 
occasionally a computer lag that caused the IPI to be measured at a shorter duration than 30 sec. 
There was one bout in which puff durations exceeded 100 sec, which was obviously an error in 
measurement. This bout was excluded from data analyses, which has been done in another ECIG 
topography study when puff durations exceeded 20 sec (Robinson et al., 2016). 
Conclusions and Future Directions 
 Given the small sample size, it is difficult to draw definitive conclusions from this study. 
One potential conclusion from this study is the reduction of withdrawal symptoms associated 
with ECIG use, as this was reliably shown for multiple measures and bouts. However, evaluating 
measurement method validity and reliability, the main purpose of the study, is difficult under the 
current conditions. While the topography devices did not differ significantly for puff number, 
duration, or IPI, the study was potentially underpowered to detect statistically significant 
differences. Additionally, differences in flow rate and volume were not assessed in this study, 
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which may differ between measurement methods. Future research should employ similar 
methods with a full sample size to evaluate the topography devices in the current study, as well 
as other methods being used to evaluate ECIG puff topography. Additionally, it is imperative for 
ECIG puff topography research to include measurements of plasma nicotine levels, in an effort 
to verify abstinence as well as examine nicotine delivery.  Similarly, more research comparing 
video and topography device measurement should be conducted to determine the consistencies 
and inconsistencies of these methods, and if the low correlations for specific conditions in this 
study were a random or replicable finding. Finally, more natural environment topography studies 
must be conducted to assess how lab paradigms of puffing differ from typical behavior.  
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Table 1
Mean (SD) or % for demographic and product use characteristics
Total     
(N=12)
ECIG-Experienced 
(n=7)
ECIG-Naïve 
(n=5)
Age (years) 28.75 (11.48) 28.00 (11.33) 29.80 (12.95)
% Male 100 100 100
% White 83 86 80
% Non-Hispanic 100 100 100
Education (years) 14.00 (2.62) 14.70 (3.04) 13.00 (1.73)
Cigarettes Per Day 14.60 (3.65)
Years Smoking 4.00 (6.16)
Carbon Monoxide (ppm) 19.60 (13.72)
FTND Scorea 4.80 (1.64)
Penn State ECIG Dependence Indexb 7.29 (4.03)
ECIG Liquid Per Day (ml) 4.79 (3.74)
Years ECIG Use 1.96 (1.21)
ECIG Liquid Nicotine (mg/ml) 12.86 (7.29)
aFagerstrom Test for Nicotine Dependence (range 0-10)
bPenn State ECIG Dependence Index (range 0-20)
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Table 2
Correlation coefficients for rater scores by operational definition
Lip Definition Light Definition
Puff Numbera
     Directed 0.56* 0.80**
     Ad lib 1 1.00** 0.91**
     Ad lib 2 1.00** 0.94**
Puff Durationb
     Directed 0.92** 0.93**
     Ad lib 1 0.95** 0.87**
     Ad lib 2 0.96** 0.97**
Inter-Puff-Intervalb
     Directed 0.56** 0.42**
     Ad lib 1 0.99** 0.98**
     Ad lib 2 0.99** 1.00**
** p  < .01, * p  < .05
a Data analyzed using Intraclass Correlation
b Data analzyed using Pearson's Correlation Coefficient
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Table 4
Correlation coefficients for data collected via computerized device and direct observation methods
1 2 3 1 2 3
eTop2 vs. Video 
     Puff Number
Lip Definition -0.17 0.88** 0.89** 0.41 0.62 -0.34
Light Definition -0.55 0.94** 0.96** 0.51 0.05 0.03
     Puff Duration
Lip Definition 0.59** 0.47** 0.23 0.60** 0.59** 0.38**
Light Definition 0.53** 0.38** 0.26* 0.78** 0.49** 0.20
     Inter-Puff-Interval
Lip Definition -0.06 0.69** 0.63** -0.08 0.22 0.29
Light Definition -0.06 0.23 0.65** -0.03 0.29 0.33
eTop vs. Video
     Puff Number
Lip Definition -0.28 0.86* 0.91* 0.41 0.8 0.98**
Light Definition -0.06 0.97** 0.95** 0.51 0.08 0.8
     Puff Duration
Lip Definition 0.55** 0.30* 0.30* 0.50** 0.50** 0.29*
Light Definition 0.52** 0.20 0.40** 0.68** 0.41* 0.19
     Inter-Puff-Interval
Lip Definition -0.06 0.48** 0.28* -0.06 0.48** 0.28
Light Definition -0.05 0.10 0.36* -0.05 0.42* 0.18
** p  < .01, * p  < .05
ECIG-Experienced ECIG-Naïve
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Table 5
Correlation coefficients for topography via computerized devices and videos of computerized device use
1 2 3 1 2 3
eTop2 vs. Video of eTop2
     Puff Number
Lip Definition n/aa 1.00** 1.00** 0.17 0.17 0.78
Light Definition 0.28 0.89** 0.88** -0.04 -0.42 0.86
     Puff Duration
Lip Definition 0.86** 0.95** 0.82** 0.95** 0.84** 0.93**
Light Definition 0.85** 0.88** 0.91** 0.98** 0.81** 0.94**
     Inter-Puff-Interval
Lip Definition 0.10 0.99** 0.98** 0.66** 0.95** 0.84**
Light Definition 0.08 1.00** 0.99** 0.74** 0.94** 0.86**
eTop vs. Video of eTop
     Puff Number
Lip Definition 0.18 0.99** 0.99** 0.61 0.93* 0.55
Light Definition -0.27 0.97** 0.99** -0.69 -0.10 0.57
     Puff Duration
Lip Definition 0.95** 0.76** 0.95** 0.93** 0.99** 0.99**95**
Light Definition 0.92** 0.47** 0.92** 0.93** 0.85** 0.95**
     Inter-Puff-Interval 
Lip Definition 0.35** 1.00** 1.00** 0.99** 0.90** 0.75**
Light Definition 0.73** 0.99** 1.00** 0.56** 0.88** 0.52*
** p  < .01, * p  < .05
a n/a due to lip definition having a constant value (i.e., all values are 10 puffs)
ECIG-NaïveECIG-Experienced
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Table 6
Mean (SD) for puff topography measures for device by group
ECIG- Naïve ECIG-Experienced ECIG- Naïve ECIG-Experienced ECIG- Naïve ECIG-Experienced
Puff Number 10.33 (1.40) 10.62 (6.84) 11.53 (2.61) 10.05 (5.28) 10.10 (1.86) 10.64 (6.10)
Puff Volume (ml) 62.22 (39.52) 41.17 (18.49) 89.38 (64.71) 62.40 (34.67) n/a n/a
Puff Duration (sec) 3.89 (1.88) 3.91 (1.38) 3.77 (2.01) 3.52 (1.35) 4.49 (2.10) 3.58 (1.17)
Inter-Puff-Interval (sec) 28.11 (5.94) 39.24 (47.36) 25.84 (5.66) 30.63 (22.39) 28.37 (6.31) 33.01 (28.48)
Flow Rate (ml/sec) 16.27 (7.98) 11.16 (4.47) 24.91 (14.04) 18.03 (8.91) n/a n/a
Data are collapsed across bout
eTop 2.0 eTop Video
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Table 7
Mean (SD) for acceptability items for device by group
ECIG- Naïve ECIG-Experienced ECIG- Naïve ECIG-Experienced ECIG- Naïve ECIG-Experienced
Alter Behavior 46.60 (32.08) 15.29 (37.39) 44.40 (39.77) 24.57 (38.09) 38.00 (22.12) 23.43 (37.05)
Less Likely 34.60 (31.32) 14.57 (28.48) 32.60 (38.42) 20.71 (36.55) 32.60 (33.34) 7.14 (16.32)
Reduce Enjoyment 29.00 (25.23) 28.71 (33.88) 25.60 (24.76) 35.43 (38.11) 40.2 (30.74) 21.29 (39.22)
Affect Taste 39.60 (38.21) 16.71 (27.88) 29.20 (27.36) 34.14 (39.41) 13.20 (15.55) 13.43 (17.96)
More Difficult 36.80 (34.45) 38.14 (45.18) 23.20 (24.30) 33.00 (40.44) 24.40 (18.04) 7.29 (16.40)
Increase Awareness 44.20 (27.46) 22.14 (25.60) 27.80 (18.99) 35.86 (38.56) 47.00 (28.11) 25.14 (28.23)
Like to Know More 51.60 (41.38) 76.14 (35.44) 50.40 (33.84) 70.43 (34.28) 59.60 (33.10) 69.00 (30.94)
Data are collapsed across bout
eTop 2.0 eTop Video
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Table 8         !! !!
Mean (SE) for subjective outcomes and heart rate at different timepoints 
              
    Baseline !! Post-directed !! Post-ad lib 1 
Hughes Hatsukami     !!   !!   
     Urges   50.67 (10.21) !! 24.64 (6.36) !! 19.06 (5.41) 
     Irritable   27.11 (9.52) !! 7.17 (3.35) !! 4.75 (2.55) 
     Craving   51.31 (10.35) !! 21.58 (5.48) !! 17.33 (6.07) 
      !!   !!   
Tiffany Drobes QSU     !!   !!   
     Factor 1   18.06 (3.01) !! 10.14 (2.18) !! 8.06 (2.11) 
     Factor 2   7.22 (2.22) !! 2.89 (1.08) !! 1.86 (0.99) 
      !!   !!   
Direct Effects of ECIG 
Use   !!   !!   
     Satisfying   10.75 (6.47) !! 47.14 (11.60) !! 46.42 (11.63) 
     Pleasant   9.94 (5.99) !! 43.14 (10.77) !! 42.39 (11.41) 
     Taste Good   9.33 (5.35) !! 26.50 (9.87) !! 31.58 (10.96) 
      !!   !!   
Heart Rate   72.73 (2.68) !! 79.53 (2.58) !! 77.06 (2.34) 
Data are collapsed across measurement method and group !! !!
Scores at the post-directed bout and post-ad lib 1 bout are significantly different  
from scores at baseline for all outcomes shown 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 !! !!
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Appendix A  
 
Telephone Screening Questionnaire 
 
Date: _______________     Interviewer: _______________ 
 
Interviewer:  “I would like to ask you some questions about yourself and your health status as 
well as your use of tobacco, alcohol, and other drugs. The purpose of these questions is to 
determine whether or not you are eligible to participate in the study that I just described to you.  
All of your responses are confidential.  You are not required to answer any question and you may 
stop this interview at any time. May I begin the questions?” 
 
Document caller’s response by circling either:    Yes      or      No 
 
If Yes: begin form.  If No: thank the caller and stop the interview. 
--------------------------------------------------------------------------------------------------------------------- 
How did you hear about us/our study?    ________________________ 
Personal Information: 
1.  “What is your first name?”      ________________________ 
2.  “What is a phone number at which you can be contacted?”  ________________________ 
3.  “If we call and you are not available, may we leave a message?”   Yes      or      No 
4.  “What is your date of birth?”      ________________________  
 
General health status: 
1.  “Are you currently under a doctor’s care for a medical condition?” Yes      or      No 
If Yes: “Please describe the concern or problem”: 
2.  “Do you have any chronic health concerns or problems?”   Yes      or      No 
  If Yes: “Please describe the condition”: 
3.  “Are you taking any prescription or over-the-counter medications?” Yes      or      No 
If Yes: “Please identify the medication”: 
4.  Do you have any psychiatric conditions like depression or anxiety?  Yes      or      No 
If Yes: “Please describe the condition”: 
5.  “Have you ever been diagnosed with high or low blood pressure?”  Yes      or      No 
  If Yes: “Please indicate whether it is high or low”: 
For women only: 
6.  “Are you currently pregnant?”      Yes      or      No 
7.  “Are you currently breast-feeding a child?”    Yes      or      No 
--------------------------------------------------------------------------------------------------------------------- 
Cigarette Use: 
1.  “Do you currently smoke tobacco cigarettes?”    Yes      or      No 
If No: Skip to the section on electronic cigarette use 
2.  “What brand of cigarettes do you smoke?”    _________________ 
 
Regular / Light / Ultra-light   Hard / Soft Pack     Regular / Menthol     Regular / 100s / Other 
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3.  “On average, how many cigarettes do you smoke per day?”  __________(numb of 
cigs) 
[Guide to report one number that best represents their average/day; do not provide a 
range] 
4.  “For how long have you smoked this number per day?”           __________(months / 
years) 
--------------------------------------------------------------------------------------------------------------------- 
Electronic Cigarette Use: 
1.  “Do you currently use an electronic cigarette?” Yes      or      No 
If No: Skip to the section on other tobacco use 
2.  “What model/brand of ECIG do you own?   ____________________ 
 a) If own multiple, which do you use most frequently?    ____________________ 
3.  “What nicotine concentration of e-liquid do you use?”    ________________(mg/ml) 
4.  “What flavor of e-liquid do you use?”    ____________________ 
5.  “On average, how many days per week do you use an ECIG?” ____________________ 
6.  “How much e-liquid/How many cartridges do you use per day?_________________(ml or #) 
[Guide to report one number that best represents their average/day; do not provide a 
range] 
7.  “For how long have you used that amount of product?”    __________(months / years) 
--------------------------------------------------------------------------------------------------------------------- 
Other Tobacco Use: 
1.  “Have you used any of the following other nicotine/tobacco products in the past month?”   
 
   
If ‘yes’, estimate how many days 
you have used this product in the 
past month? 
Large cigars No Yes  
Cigarillos (e.g., Black & Milds) 
or small cigars No Yes  
Waterpipe (a.k.a. hookah or 
shisha) No Yes  
Smokeless tobacco 
(snuff/dip/chew/snus) No Yes  
Electronic Cigarette (if cigarette 
smoker) No Yes  
Other: _______________ No Yes   
 
 
Smoking Cessation History: 
1. “Are you currently using any nicotine replacement products?”   Yes      or      No 
      (e.g., patch, gum, inhaler, nasal spray) 
2. “Are you currently using any prescription medications for cessation?”  Yes      or      No 
    (e.g., Chantix, Zyban, etc.) 
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-------------------------------------------------------------------------------------------------------------------- 
Illicit Drug Use: 
 
1. “Have you used any of the following other drugs for recreational purposes in the past 
month?” 
 
   If ‘yes’, estimate how many 
days you have used this 
product in the past month? 
Alcohol No Yes  
Marijuana / Spice / K2 No Yes  
Stimulants (e.g., 
cocaine, 
amphetamine, 
etc.) 
No Yes  
Opiates (e.g., heroin, 
oxycodone, 
etc.) 
No Yes  
Other: No Yes 
 
 
 
Interviewer:  “Thank you for responding to these questions.  I need to pass on your responses to 
the principal investigator who will then determine whether or not you are eligible to participate 
in a study.  If you are eligible, someone will contact you within approximately one week. If you 
are not eligible for this study, then you will not be contacted.” 
 [If respondent does not have a phone, they can call us back in a few days] 
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Appendix B 
 
Demographic Information 
______________________________________________________________________________  
 
Participant ID: ______________    Today’s Date : _____________ 
 
 
Age  
 
Years: __________    Date of birth _____________________  
______________________________________________________________________________  
 
Ethnicity  
 
o Hispanic or Latino    o Not Hispanic or Latino  
______________________________________________________________________________  
 
Race  
 
o American Indian/Alaskan Native  o Asian/Native Hawaiian or other Pacific Islander  
 
o Black or African American   o White   o Other/Unknown  
______________________________________________________________________________  
 
Gender  
 
o Male      o Female  
______________________________________________________________________________  
 
Marital status  
 
o Single  o Married  o Separated  o Divorced  o Widowed  
______________________________________________________________________________  
 
Education  
 
Years: __________ (For example, High school = 12, College degree = 16, etc.)  
______________________________________________________________________________  
 
Primary employment  
 
o Unemployed    o Part Time (0-30 hrs/wk)    o Full Time (>30 hrs/wk)  o Student  
______________________________________________________________________________ 
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Appendix C 
 
Medical History and Drug Use Form 
 
 Participant ID: ___________      Date: ______________ 
 
 General health status:  
 
Are you under a doctor’s care for a medical condition?____________ (If yes, please describe 
below)  
 
Are you taking any prescription medications?       ________ (If yes, please identify below)  
 
Do you have any chronic health concerns or problems?  ________ (If yes, please describe below)  
 
Do you have any psychiatric conditions?        ________ (If yes, please describe below) 
 
For women only:  
 
Are you currently pregnant?   _______ (yes or no)  
 
Are you currently breast-feeding a child? ______ (yes or no)  
 
Cigarette Use:  
 
Do you currently smoke tobacco cigarettes? ________ (yes or no) if no, skip to the next section  
 
On average, how many cigarettes per day do you smoke? ____________  (number of cigarettes)  
 
For how long have you smoked the above number of cigarettes per day? ________ (months or 
years)  
 
What brand of cigarettes do you smoke?  ___________________  
 
Regular, light, or ultra-light?     __________________  
 
Menthol or Non-menthol?    ___________________  
 
Hard pack or soft pack?     ___________________  
 
King size or 100s?      ___________________ 
 
ECIG Use: 
 
Do you currently use an ECIG?   ________ (yes or no) if no, skip to the next section 
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How many days per week do you use an ECIG? __________________ (number of days) 
 
On average, how much e-liquid/how many cartidges do you use per day? 
__________________(milliliters or number)  
 
What nicotine concentration of e-liquid do you use? __________________ (mg/ml or %) 
 
For how long have you been using an ECIG?  _________________ (months/years) 
 
What model ECIG do you use most frequently?  __________________  
 
What flavor of e-liquid do you use most frequently? _________________  
 
 
History of Quit Attempts:  
 
Have you ever made an attempt to quit or reduce your smoking? ____________ (yes or no) if no, 
skip to the next section  
 
Have you made any attempts to quit or reduce your smoking in the last 30 days? ____________  
 
Other Tobacco Use:  
 
Do you currently use any other nicotine/tobacco products? ____________ (yes or no)  
 
Circle all products below that you have used in the past 30 days:  
 
Cigars / cigarillos / small cigars   Smokeless tobacco (snuff, dip, chew) / snus 
 
Hookah / waterpipe     Electronic cigarette 
 
Nicotine gum / patch / lozenge / inhaler  Other: ________________________ 
 
Alcohol Use:  
 
Have you used alcohol in the past month? ________ (yes or no) if no, skip to the next section  
 
How many days out of the last 30 have you used alcohol? __________________ (number of 
days)  
 
Have you ever been treated for alcohol abuse/dependence? __________________ (yes or no)  
 
Other Drug Use:  
 
Have you used any illegal drugs within the past month? ________ (yes or no)  
If yes, please identify which drugs: ______________________________________  
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Appendix D 
 
Fagerström Test for Nicotine Dependence 
Please answer the following questions (mark an X in one box only): 
1. ! How soon after you wake up do you smoke your first cigarette? 
          Within             Within        Within        After 
        5 minutes                  6-30 minutes            31-60 minutes               60 minutes 
                                          
    
 
2. ! Do you find it difficult to refrain from smoking in places where it is forbidden (e.g., in 
church, at the library, at the movies)? 
    Yes           No 
                                      
            
 
3. ! Which cigarette would you hate to give up the most?   
       The first one in the morning     All others 
        
 
 
4. ! How many cigarettes a day do you smoke? 
         10 or less            11-20         21-30               31 or more 
                                           
 
   
5. ! Do you smoke more frequently during the first hours after waking than during the rest of the 
day? 
Yes           No 
                                      
            
 
6. ! Do you smoke if you are so ill that you are in bed most of the day? 
 
Yes           No 
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Appendix E 
 
Penn State Electronic Cigarette Dependence Index 
                                               
Please answer the following questions (mark an X in one box only): 
 
1. ! How many times per day do you usually use your electronic cigarette? (assume that one 
“time” consists of around 15 puffs or lasts around 10 minutes) 
0-4             5-9           10-14           15-19  20-29  30+ 
                                          
                                 
 
2. ! On days that you can use your electronic cigarette freely, how soon after you wake up do you 
first use your electronic cigarette? 
 
         0-5 min          6-15 min        16-30 min         31-60 min      61-120 min       121+ min 
                                          
                                 
 
3. ! Do you sometimes awaken at night to use your electronic cigarette? 
 
    Yes           No 
                                      
            
 
 
4. ! If yes, how many nights per week do you typically awaken to use your electronic cigarette? 
           0-1 night              2-3 nights                     4+ nights                              
                          
    
 
5. ! Do you use an electronic cigarette now because it is really hard to quit? 
Yes           No 
                                      
            
 
6. ! Do you ever have strong cravings to use an electronic cigarette? 
 
Yes           No 
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7.! Over the past week, how strong have the urges to use an electronic cigarette been? 
 
                 None/Slight         Moderate/Strong       Very Strong/Extremely Strong 
 
 
 
 
8.! Is it hard to keep from using an electronic cigarette in places where you are not supposed to? 
 
Yes           No 
                                     
 
 
When you haven’t used an electronic cigarette for a while or you tried to stop using… 
 
9.! Did you feel more irritable because you could use and electronic cigarette? 
 
Yes           No 
                                     
 
 
10.! Did you feel nervous, restless, or anxious because you couldn’t use an electronic cigarette? 
 
Yes           No 
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Appendix F 
 
Acceptability Questionnaire 
 
 
 
 
 
1. Alter your smoking behavior today? 
 
 
2. Make you less likely to want  
    to smoke today? 
 
3. Reduce your smoking enjoyment 
    today? 
 
4. Affect the taste of the cigarettes 
    you smoked today? 
 
5. Make smoking more difficult 
    today? 
 
6. Increase your awareness of how 
    much you smoked today? 
 
  
Please respond to each question by making a vertical mark anywhere along the horizontal line.   
 
Did the laboratory environment and/or the computerized equipment: 
 
Not at all Extremely 
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Appendix G 
 
Hughes & Hatsukami (1986) 
 
 
 
 
 
 
1. URGES to smoke 
 
2. Irritability/frustration/anger  
 
3. Anxious 
 
4. Difficulty concentrating 
 
5. Restlessness 
 
6. Hunger 
 
7. Impatient 
 
8. CRAVING a cigarette/nicotine 
 
9. Drowsiness 
 
10. Depression/feeling blue 
 
11. Desire for sweets 
  
These phrases may or may not describe how you feel right now.  Please respond to each 
word or phrase with how you feel RIGHT NOW by drawing a vertical mark anywhere 
along the horizontal line. 
Not at all Extremely 
MEASUREMENT OF ELECTRONIC CIGARETTE TOPOGRAPHY 80  
Appendix H 
 
Questionnaire of Smoking Urges – Brief 
 
 
 
1. I have a desire for a cigarette right now. 
 
 
 
2. Nothing would be better than smoking 
    a cigarette right now. 
 
 
 
3. If it were possible, I probably would 
    smoke now. 
 
 
 
4. I could control things better right now 
    if I could smoke. 
 
 
5. All I want right now is a cigarette. 
 
 
 
 
6. I have an urge for a cigarette. 
 
 
 
7. A cigarette would taste good now. 
 
 
 
 
8. I would do almost anything for a 
    cigarette now. 
 
 
 
 
 
 
For each item, please indicate how you feel RIGHT NOW. 
Strongly 
disagree 
Strongly 
   agree 
Strongly 
disagree 
Strongly 
   agree 
Strongly 
disagree 
Strongly 
   agree 
Strongly 
disagree 
Strongly 
   agree 
Strongly 
disagree 
Strongly 
   agree 
Strongly 
disagree 
Strongly 
   agree 
Strongly 
disagree 
Strongly 
   agree 
Strongly 
disagree 
Strongly 
   agree 
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9. Smoking would make me less depressed. 
 
 
 
 
10. I am going to smoke as soon as possible. 
 
 
 
 
 
 
 
  
Strongly 
disagree 
Strongly 
   agree 
Strongly 
disagree 
Strongly 
   agree 
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Appendix I 
 
Direct Effects of Nicotine Scale 
 
 
 
 
 
 
 
 
1. Nauseous 
 
 
2. Dizzy 
 
 
3. Lightheaded 
 
 
4. Nervous 
 
 
5. Sweaty 
 
 
6. Headache 
 
 
7. Excessive salivation 
 
 
8. Heart pounding 
 
 
9. Confused  
 
 
10. Weak 
 
  
These phrases may or may not describe how you feel right now.  Please respond to 
each word or phrase with how you feel RIGHT NOW by drawing a vertical mark 
anywhere along the horizontal line. 
Not at all Extremely 
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Appendix J 
 
Direct Effects of ECIG USE 
 
 
 
 
 
 
 
 
 
 
1. Was the product satisfying? 
 
 
2.  Was the product pleasant?  
 
 
3.  Did the product taste good?  
 
 
4.  Did the product make you dizzy? 
 
 
5.  Did the product calm you down? 
 
 
6.  Did the product help you concentrate? 
 
 
7.  Did the product make you feel more awake? 
 
 
8.  Did the product reduce your hunger for food? 
 
 
9. Did the product make you sick? 
 
 
 
 
 
These phrases may or may not describe how you feel right now.  Please respond to 
each word or phrase with how you feel RIGHT NOW by drawing a vertical mark 
anywhere along the horizontal line. 
Not at all Extremely 
